This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Learn about ATTR-CM and uncover the differences between hereditary and wild-type ATTR-CM
Menu
Close
Click here for Vyndaqel®▼ (tafamidis) Prescribing Information.
Importance of nuclear medicine for early diagnosis of ATTR-CM
Summary of Ana Martinez-Naharro's presentation at the RCR Annual Conference 2023 highlighting the importance of nuclear medicine for early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM).
Red Flags of ATTR-CM
Summary of Nigel Lewis' presentation at the BCS Symposium 2021 highlighting the red flags for ATTR-CM including the cardiac and non-cardiac manifestations.
Diagnosis of ATTR-CM
Summary of Kate Gatenby's presentation at the BCS Symposium 2021 highlighting the characteristic findings on imaging that would point to a diagnosis of ATTR-CM.
Management of ATTR-CM
Summary of Will Moody's presentation at the BCS Symposium 2021, discussing a case study of a patient diagnosed with ATTR-CM.
Tips for Detecting Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Summary video from the 2020 BSH Congress Symposium with Lisa Anderson, who shares some important tips for helping you to detect TTR cardiac amyloidosis, including example criteria of a patients history.
This module reviews the biological foundation and disease mechanism of ATTR amyloidosis.
This video breaks down the various types of ATTR amyloidosis and the clinical clues that can raise suspicion of ATTR-CM.
This module reviews the importance of an early diagnosis of ATTR-CM.
The last in the series video reviews non-invasive and invasive approaches for the diagnosis of ATTR-CM.
From Suspicion to Diagnosis: The ATTR-CM Journey
This is a downloadable PowerPoint presentation to support peer-to-peer education.This presentation contains an overview of cardiac amyloidosis, recognising ATTR-CM red flags, understanding the diagnostics, the treatment landscape and the role of the multi-disciplinary team.
Red flags leave piece that looks at ATTR-CM, the signs to suspect ATTR-CM and the tools that help diagnose ATTR-CM.
Dr Nigel Lewis (Northern General Hospital, Sheffield
Dr Kate Gatenby (Leeds General Infirmary, Leeds
Dr William Moody (Queen Elizabeth Hospital, Birmingham & the Midlands Amyloid Service)
Detect, differentiate and diagnose: Identifying and managing ATTR-CM
Catch up with our panel of expert speakers from the BCS 2021 as they describe the clinical journey of a patient with ATTR-CM from detection through to diagnosis and management.
Prescribing information:
Aldactone (spironolactone) 25mg tablets
Aldactone (spironolactone) 50mg tablets
Aldactone (spironolactone) 100mg tablets
Dr Lisa Anderson (St George's Hospital, London)
Dr Robert Cooper (Liverpool Heart and Chest Hospital, Liverpool)
Future directions for management of cardiac amyloidosis
Dr Lisa Anderson provides an overview of the diagnosis and early management of cardiac amyloidosis and Dr Robert Cooper discusses the emerging treatment strategies.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024